132 related articles for article (PubMed ID: 8656666)
1. Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension.
Savolainen A; Keto P; Poutanen VP; Hekali P; Standertskjöld-Nordenstam CG; Rames A; Kupari M
J Cardiovasc Pharmacol; 1996 Jan; 27(1):99-104. PubMed ID: 8656666
[TBL] [Abstract][Full Text] [Related]
2. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.
Pannier BM; Guerin AP; Marchais SJ; London GM
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1074-7. PubMed ID: 11903319
[TBL] [Abstract][Full Text] [Related]
3. Long-term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta-blockade.
Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A
Am J Hypertens; 1996 Sep; 9(9):850-3. PubMed ID: 8879340
[TBL] [Abstract][Full Text] [Related]
4. Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta.
Breithaupt-Grögler K; Leschinger M; Belz GG; Butzer R; Erb K; de May C; Sinn W
Cardiovasc Drugs Ther; 1996 Mar; 10(1):49-57. PubMed ID: 8723170
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of cilazapril and atenolol on P-wave dispersion in patients with hypertension.
Tuncer M; Gunes Y; Guntekin U; Gumrukcuoglu HA; Eryonucu B
Adv Ther; 2008 Feb; 25(2):99-105. PubMed ID: 18297254
[TBL] [Abstract][Full Text] [Related]
6. Correction of remodeling and function of small arteries in human hypertension by cilazapril, an angiotensin I-converting enzyme inhibitor.
Schiffrin EL
J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S13-8. PubMed ID: 8723394
[TBL] [Abstract][Full Text] [Related]
7. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
8. Effect of different antihypertensive drug classes on central aortic pressure.
Morgan T; Lauri J; Bertram D; Anderson A
Am J Hypertens; 2004 Feb; 17(2):118-23. PubMed ID: 14751652
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension.
Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A
Blood Press; 1995 Mar; 4(2):85-90. PubMed ID: 7599759
[TBL] [Abstract][Full Text] [Related]
10. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.
Schiffrin EL; Deng LY; Larochelle P
Hypertension; 1994 Jan; 23(1):83-91. PubMed ID: 8282334
[TBL] [Abstract][Full Text] [Related]
11. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
Derman WE; Sims R; Noakes TD
J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S122-7. PubMed ID: 1381788
[TBL] [Abstract][Full Text] [Related]
12. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.
Schiffrin EL; Deng LY; Larochelle P
Am J Hypertens; 1995 Mar; 8(3):229-36. PubMed ID: 7794571
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibition versus conventional antihypertensive therapy on the glomerular filtration rate.
Hansson L
Cardiology; 1995; 86 Suppl 1():30-3. PubMed ID: 7614504
[TBL] [Abstract][Full Text] [Related]
14. [Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension].
Schiffrin EL; Deng LY; Larochelle P
Arch Mal Coeur Vaiss; 1994 Aug; 87(8):979-81. PubMed ID: 7755476
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure.
Nakanishi T; Takahashi H; Nishimura M; Yoshimura M
Clin Ther; 1993; 15(2):294-303. PubMed ID: 8519038
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
Hausberg M; Barenbrock M; Hohage H; Müller S; Heidenreich S; Rahn KH
Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
[TBL] [Abstract][Full Text] [Related]
17. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
Schiffrin EL
Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
[TBL] [Abstract][Full Text] [Related]
18. Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.
Pannier BE; Garabedian VG; Madonna O; Fouchard M; Darne B; Safar ME
Cardiovasc Drugs Ther; 1991 Aug; 5(4):775-81. PubMed ID: 1653594
[TBL] [Abstract][Full Text] [Related]
19. Review of studies on the clinical pharmacodynamics of cilazapril.
Belz GG; Breithaupt K; Erb K
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
[TBL] [Abstract][Full Text] [Related]
20. Alpha-adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor.
Rosendorff C; Patton J; Radford HM; Kalliatakis B
J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S105-9. PubMed ID: 1382157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
